课题基金 / 基金详情

Chemoprevention of oral cancer: model studies

Chemoprevention of oral cancer: model studies
口腔癌的化学预防:模型研究
批准号:
6493614
负责人:
KARAM E EL-BAYOUMY
金额:
$16.24万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-01 至 2003-08-31

项目摘要

项目成果

KARAM E EL-BAYOUMY的其他基金

相似基金

相关文献

中文摘要
翻译
虽然通过戒烟和适度饮酒进行初级预防应该是控制头颈癌最成功的策略,但评价诸如化学预防等补充方法作为实现这一目标的手段非常重要。维生素A(类维生素A)、β -胡萝卜素、维生素E和硒的天然和合成类似物在头颈癌的化学预防研究中都有报道。文献数据似乎支持这样一种观点,即维生素和矿物质的混合物的化学预防效果优于单一药剂。缺乏数据表明,由于化学预防剂的大规模干预试验,口腔癌和其他头颈癌的发病率和死亡率有所下降。在这个时候,建议补充特定的化学预防剂作为预防头颈癌的常规策略似乎为时过早。因此,本研究的基础是系统地确定相关药物单独或联合的疗效;最初,在定义良好的动物模型分析和描述的作用机制涉及的病因和预防。我们展示了lacZ转基因小鼠在研究合成4-硝基喹啉-n -氧化物(4- nqo)引发口腔癌变以及烟草及其热解产物(4-(甲基亚硝胺)-1-(3-吡啶基)-1-丁酮[NNK]和苯并(a)芘[BaP])中存在的致癌物中的用途。我们还证明,在一些器官(包括口腔组织)中添加合成有机硒化合物(1,4-苯双(亚甲基)硒氰酸酯,p-XSC)或维生素E和C的日粮可以在不同程度上抑制诱变,该系统可用于评估其他化学预防剂。此外,我们已经证明,在F344大鼠中,p-XSC可以抑制舌肿瘤,阻断4-NQO诱导的细胞增殖。此外,我们实验室以及其他实验室获得的结果清楚地表明,硒化合物的一种形式,而不是硒本身,在癌症化学预防中至关重要。根据我们的初步结果和文献报道,我们假设以p-XSC形式的硒或自然存在的硒甲基硒半胱氨酸(MSC),维生素A和E的组合应该被证明是非常有希望的化学预防口腔癌的鸡尾酒。具体来说,这种混合物会抑制氧化损伤、细胞增殖和COX-2活性;这将导致诱导细胞凋亡和抑制肿瘤发生。为了验证我们的假设,我们的具体目标是:1。探讨硒(MSC和p-XSC)、维生素A和E单独或联合对lacZ转基因小鼠口腔4-NQO和BaP诱变的抑制作用。2. 目的:确定最有效的鸡尾酒(在Aim 1中开发)分别对雄性F344大鼠和雌性B6C3F小鼠4-NQO和BaP诱导的舌肿瘤发展的化学预防效果。3. 研究鸡尾酒对大鼠和小鼠舌头关键中间生物标志物(细胞增殖、氧化、DNA损伤、cox活性和凋亡)的影响。该项目的结果将为在未来的口腔癌化学预防临床试验中使用最有效的鸡尾酒的可行性提供见解。
英文摘要
Although primary prevention by tobacco use cessation and by moderation in alcohol intake should be the most successful strategy for control of head and neck cancer, the evaluation of complementary approaches, such as chemoprevention, is very important as a means toward achieving this goal. Natural and synthetic analogs of vitamin A (retinoids), beta-carotene, vitamin E and selenium are featured in the reported studies of chemoprevention of head and neck cancer. Literature data appear to support the notion that the chemopreventive efficacy of a mixture of vitamins and minerals is superior to a single agent. Data showing a reduction in the incidence and mortality rates of oral and other head and neck cancers as a result of large-scale intervention trials with chemopreventive agents are lacking. At this time, it appears premature to suggest supplementation of specific chemopreventive agents as a routine strategy to prevent head and neck cancer. Therefore, the basis of the present investigation is to systematically determine the efficacy of relevant agents, individually and in combination; initially, in well-defined animal model assays and with delineation of the mechanisms of action involved in etiology and prevention. We demonstrated the utility of the lacZ transgenic mouse for investigations involving initiation pf carcinogenesis of the oral cavity by synthetic 4-nitroquinoline-N-oxide (4-NQO), as well as carcinogens present in tobacco and its pyrolysis products (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone [NNK] and benzo(a)pyrene [BaP]). We also demonstrated that a diet supplemented with a synthetic organoselenium compound (1,4-phenylenebis(methylene)selenocyanate, p-XSC)) or with vitamin E and C in several organs, including oral tissues, can inhibit mutagenesis to varying extents and the system can be used to evaluate other chemopreventive agents. In addition, we have shown that, in F344 rats, p-XSC can inhibit tumors of the tongue and block the cell proliferation induced by 4-NQO. Furthermore, results obtained in our laboratory, as well as in others, clearly demonstrate that a form of selenium compound, not selenium per se, is critical in cancer chemoprevention. On the basis of our preliminary results and those reported in the literature, we hypothesize that the combination of selenium in the form of p-XSC or the naturally-occurring Se-methylselenocysteine (MSC), vitamin A, and E should prove to be highly promising cocktail for chemoprevention of cancer of the oral cavity. Specifically, this cocktail will inhibit oxidative damage, cell proliferation and COX-2 activity; this will result in induction of apoptosis and inhibition of tumorigenesis. To test our hypothesis, our specific aims are: 1. To determine the inhibition of mutagenesis induced by 4-NQO and BaP in the oral cavity of the lacZ transgenic mouse by selenium (MSC and p-XSC), vitamin A, and E individually and in combination. 2. To determine the chemopreventive efficacy of the most effective cocktail (developed in Aim 1) against the development of tumors of the tongue induced by 4-NQO and BaP in male F344 rats, and in female B6C3F mice, respectively. 3. To examine the effect of the cocktail on critical intermediate biomarkers (cell proliferation, oxidative, DNA damage, COX-activities, and apoptosis) in the tongue of the rat and mouse. The results of this project will provide insights regarding the feasibility of using the most effective cocktail in future clinical trials toward chemoprevention of oral cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Metabolic activation of nitroarenes and Nrf2-Keap1
  • 批准号:
    10394949
  • 项目类别:
  • 资助金额:
    $46.89万
  • 财政年份:
    2019
  • 负责人:
    KARAM E EL-BAYOUMY
  • 依托单位:
Metabolic activation of nitroarenes and Nrf2-Keap1
  • 批准号:
    10178027
  • 项目类别:
  • 资助金额:
    $46.88万
  • 财政年份:
    2019
  • 负责人:
    KARAM E EL-BAYOUMY
  • 依托单位:
Metabolic activation of nitroarenes and Nrf2-Keap1
  • 批准号:
    9927641
  • 项目类别:
  • 资助金额:
    $46.8万
  • 财政年份:
    2019
  • 负责人:
    KARAM E EL-BAYOUMY
  • 依托单位:
Metabolic activation of nitroarenes and Nrf2-Keap1
  • 批准号:
    10617646
  • 项目类别:
  • 资助金额:
    $46.89万
  • 财政年份:
    2019
  • 负责人:
    KARAM E EL-BAYOUMY
  • 依托单位:
海外基金